Fox Run Management’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,600
Closed -$349K 1089
2026
Q1
$349K Buy
+18,600
New +$439K 0.06% 582
2025
Q2
Sell
-9,721
Closed -$287K 1011
2025
Q1
$287K Buy
+9,721
New +$361K 0.04% 684
2024
Q2
Sell
-16,725
Closed -$259K 894
2024
Q1
$259K Sell
16,725
-10,357
-38% -$117K 0.06% 574
2023
Q4
$241K Buy
+27,082
New +$200K 0.06% 572
2023
Q2
Sell
-22,415
Closed -$222K 800
2023
Q1
$222K Buy
22,415
+5,094
+29% +$44.6K 0.07% 499
2022
Q4
$111K Buy
+17,321
New +$98.6K 0.04% 556
2021
Q4
Sell
-14,834
Closed -$112K 566
2021
Q3
$112K Buy
+14,834
New +$126K 0.07% 422

Other funds holding HIMS

Fox Run Management's HIMS Position: Q2 2026 in Review

Fox Run Management sold out of Hims & Hers Health (HIMS) in Q2 2026, closing a stake of 18,600 shares — an estimated $349K sold.

Fox Run Management first reported a position in HIMS in Q3 2021 and held it in 7 quarters. The position peaked at $349K in Q1 2026. 507 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Fox Run Management reported no remaining Hims & Hers Health position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 18,600 Hims & Hers Health shares in Q2 2026, an estimated $349K.
  • Fox Run Management first reported a position in Hims & Hers Health in Q3 2021 and held it in 7 quarters.
  • Fox Run Management's Hims & Hers Health position peaked at $349K in Q1 2026.
  • 507 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.